159 related articles for article (PubMed ID: 31600581)
1. Chemometrics: a complementary tool to guide the isolation of pharmacologically active natural products.
Cornejo-Báez AA; Peña-Rodríguez LM; Álvarez-Zapata R; Vázquez-Hernández M; Sánchez-Medina A
Drug Discov Today; 2020 Jan; 25(1):27-37. PubMed ID: 31600581
[TBL] [Abstract][Full Text] [Related]
2. Innovative omics-based approaches for prioritisation and targeted isolation of natural products - new strategies for drug discovery.
Wolfender JL; Litaudon M; Touboul D; Queiroz EF
Nat Prod Rep; 2019 Jun; 36(6):855-868. PubMed ID: 31073562
[TBL] [Abstract][Full Text] [Related]
3. Natural products as a source of drug leads to overcome drug resistance.
Silver LL
Future Microbiol; 2015; 10(11):1711-8. PubMed ID: 26517443
[TBL] [Abstract][Full Text] [Related]
4. The re-emergence of natural products for drug discovery in the genomics era.
Harvey AL; Edrada-Ebel R; Quinn RJ
Nat Rev Drug Discov; 2015 Feb; 14(2):111-29. PubMed ID: 25614221
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in bio-affinity chromatography for screening bioactive compounds from natural products.
Guo J; Lin H; Wang J; Lin Y; Zhang T; Jiang Z
J Pharm Biomed Anal; 2019 Feb; 165():182-197. PubMed ID: 30553109
[TBL] [Abstract][Full Text] [Related]
6. Considerations of the chemical biology of microbial natural products provide an effective drug discovery strategy.
Choi H; Oh DC
Arch Pharm Res; 2015 Sep; 38(9):1591-605. PubMed ID: 26231248
[TBL] [Abstract][Full Text] [Related]
7. Natural Products and Cancer Stem Cells.
Marucci C; Fumagalli G; Calogero F; Silvani A; Christodoulou MS; Martinet N; Passarella D
Curr Pharm Des; 2015; 21(38):5547-57. PubMed ID: 26429713
[TBL] [Abstract][Full Text] [Related]
8. Genomic mining--a concept for the discovery of new bioactive natural products.
Gross H
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):207-19. PubMed ID: 19333866
[TBL] [Abstract][Full Text] [Related]
9. Nanomole-scale natural products discovery.
Molinski TF
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):197-206. PubMed ID: 19333865
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics for bioactivity assessment of natural products.
Yuliana ND; Khatib A; Choi YH; Verpoorte R
Phytother Res; 2011 Feb; 25(2):157-69. PubMed ID: 20658470
[TBL] [Abstract][Full Text] [Related]
11. How to translate a bioassay into a screening assay for natural products: general considerations and implementation of antimicrobial screens.
Fallarero A; Hanski L; Vuorela P
Planta Med; 2014 Sep; 80(14):1182-99. PubMed ID: 25221978
[TBL] [Abstract][Full Text] [Related]
12.
Grienke U; Foster PA; Zwirchmayr J; Tahir A; Rollinger JM; Mikros E
Sci Rep; 2019 Jul; 9(1):11113. PubMed ID: 31366964
[TBL] [Abstract][Full Text] [Related]
13. Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development.
Saeidnia S; Gohari AR; Manayi A
Curr Pharm Biotechnol; 2016; 17(11):1016-22. PubMed ID: 27396403
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel bioactive natural products driven by genome mining.
Li Z; Zhu D; Shen Y
Drug Discov Ther; 2018; 12(6):318-328. PubMed ID: 30674766
[TBL] [Abstract][Full Text] [Related]
15. Rearranged ergostane-type natural products: chemistry, biology, and medicinal aspects.
Duecker FL; Reuß F; Heretsch P
Org Biomol Chem; 2019 Feb; 17(7):1624-1633. PubMed ID: 30357222
[TBL] [Abstract][Full Text] [Related]
16. Toolbox for Antibiotics Discovery from Microorganisms.
Fisch KM; Schäberle TF
Arch Pharm (Weinheim); 2016 Sep; 349(9):683-91. PubMed ID: 27311607
[TBL] [Abstract][Full Text] [Related]
17. Data Resources for the Computer-Guided Discovery of Bioactive Natural Products.
Chen Y; de Bruyn Kops C; Kirchmair J
J Chem Inf Model; 2017 Sep; 57(9):2099-2111. PubMed ID: 28853576
[TBL] [Abstract][Full Text] [Related]
18. Screening techniques for the identification of bioactive compounds in natural products.
Fu Y; Luo J; Qin J; Yang M
J Pharm Biomed Anal; 2019 May; 168():189-200. PubMed ID: 30825802
[TBL] [Abstract][Full Text] [Related]
19. Bioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation.
Nothias LF; Nothias-Esposito M; da Silva R; Wang M; Protsyuk I; Zhang Z; Sarvepalli A; Leyssen P; Touboul D; Costa J; Paolini J; Alexandrov T; Litaudon M; Dorrestein PC
J Nat Prod; 2018 Apr; 81(4):758-767. PubMed ID: 29498278
[TBL] [Abstract][Full Text] [Related]
20. Bioactive Natural Products Prioritization Using Massive Multi-informational Molecular Networks.
Olivon F; Allard PM; Koval A; Righi D; Genta-Jouve G; Neyts J; Apel C; Pannecouque C; Nothias LF; Cachet X; Marcourt L; Roussi F; Katanaev VL; Touboul D; Wolfender JL; Litaudon M
ACS Chem Biol; 2017 Oct; 12(10):2644-2651. PubMed ID: 28829118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]